| [1] | 
																						 
											  Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136(5): E359-E386. 
											 											 | 
										
																													
																						| [2] | 
																						 
											  Fan L, Strasser WK, Li JJ, et al. Breast cancer in China[J]. Lancet Oncol, 2014, 15(7): e279-e289. 
											 											 | 
										
																													
																						| [3] | 
																						 
											  Shanle EK, Onitilo AA, Huang W, et al. Prognostic significance of full-length estrogen receptor beta expression in stage Ⅰ-Ⅲ triple negative breast cancer[J]. Am J Transl Res, 2015, 7(7): 1246-1259. 
											 											 | 
										
																													
																						| [4] | 
																						 
											  Rosin G, de Boniface J, Karthik GM, et al. Oestrogen receptors beta1 and betacx have divergent roles in breast cancer survival and lymph node metastasis[J]. Br J Cancer, 2014, 111(5): 918-926. 
											 											 | 
										
																													
																						| [5] | 
																						 
											  Sismondi P, D'Alonzo M, Pecchio S, et al. Chemoprevention or mastectomy for women at high risk of developing breast cancer[J]. Maturitas, 2015, 82(3): 271-273. 
											 											 | 
										
																													
																						| [6] | 
																						 
											  Tu ZZ, Ma YX, Tian JM, et al. Estrogen receptor β potentiates the anti-proliferative effect of raloxifene and affects the cell migration and invasion in HCT-116 colon cancer cells[J]. J Cancer Res Clin, 2012,138(7): 1091-1103. 
											 											 | 
										
																													
																						| [7] | 
																						 
											  Marotti JD, Collins LC, Hu R, et al. Estrogen receptor-beta expression in invasive breast cancer in relation to molecular phenotype: results from the nurses’ health study[J]. Mod Pathol, 2010, 23(2): 197-204. 
											 											 | 
										
																													
																						| [8] | 
																						 
											  Tan W, Li Q, Chen K, et al. Estrogen receptor beta as a prognostic factor in breast cancer patients: a systematic review and meta-analysis[J]. Oncotarget, 2016, 7(9): 121-127. 
											 											 | 
										
																													
																						| [9] | 
																						 
											  Yan Y, Li X, Blanchard A, et al. Expression of both estrogen receptor-beta 1 (ER-β1) and its co-regulator steroid receptor RNA activator protein (SRAP) are predictive for benefit from tamoxifen therapy in patients with estrogen receptor-alpha (ER-α)-negative early breast cancer (EBC)[J]. Ann Oncol, 2013, 24(8): 1986-1993. 
											 											 | 
										
																													
																						| [10] | 
																						 
											  Hou YF, Yuan ST, Li HC, et al. ERbeta exerts multiple stimulative effects on human breast carcinoma cells[J]. Oncogene, 2004, 23(34): 5799-5806. 
											 											 | 
										
																													
																						| [11] | 
																						 
											  Kim SH, Kim KY, Yu SN, et al. Autophagy inhibition enhances silibinin-induced apoptosis by regulating reactive oxygen species production in human prostate cancer PC-3 cells[J]. Biochem Biophys Res Comun, 2015, 468(1-2): 151-156. 
											 											 | 
										
																													
																						| [12] | 
																						 
											  Zheng N, Zhang P, Huang H, et al. ERα down-regulation plays a key role in silibinin-induced autophagy and apoptosis in human breast cancer MCF-7 cells[J]. J Pharmacol Sci, 2015, 128(3): 97-107. 
											 											 |